Taiwan · Delayed Price · Currency is TWD Medigen Biotechnology Statistics
Total Valuation
TPEX:3176 has a market cap or net worth of TWD 4.87 billion. The enterprise value is 6.36 billion.
| Market Cap | 4.87B |
| Enterprise Value | 6.36B |
Important Dates
The next estimated earnings date is Friday, August 21, 2026.
| Earnings Date | Aug 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:3176 has 139.31 million shares outstanding. The number of shares has decreased by -0.74% in one year.
| Current Share Class | 139.31M |
| Shares Outstanding | 139.31M |
| Shares Change (YoY) | -0.74% |
| Shares Change (QoQ) | -1.83% |
| Owned by Insiders (%) | 6.56% |
| Owned by Institutions (%) | 2.39% |
| Float | 109.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.84 |
| PB Ratio | 1.03 |
| P/TBV Ratio | 3.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.01 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.64, with a Debt / Equity ratio of 0.21.
| Current Ratio | 5.64 |
| Quick Ratio | 4.39 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.03 |
| Interest Coverage | -8.88 |
Financial Efficiency
Return on equity (ROE) is -7.45% and return on invested capital (ROIC) is -7.44%.
| Return on Equity (ROE) | -7.45% |
| Return on Assets (ROA) | -2.27% |
| Return on Invested Capital (ROIC) | -7.44% |
| Return on Capital Employed (ROCE) | -3.92% |
| Weighted Average Cost of Capital (WACC) | 5.16% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.19 |
| Inventory Turnover | 0.87 |
Taxes
In the past 12 months, TPEX:3176 has paid 73.84 million in taxes.
| Income Tax | 73.84M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +14.97% in the last 52 weeks. The beta is 0.27, so TPEX:3176's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | +14.97% |
| 50-Day Moving Average | 33.79 |
| 200-Day Moving Average | 32.22 |
| Relative Strength Index (RSI) | 57.94 |
| Average Volume (20 Days) | 409,171 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:3176 had revenue of TWD 1.27 billion and -252.36 million in losses. Loss per share was -1.82.
| Revenue | 1.27B |
| Gross Profit | 657.17M |
| Operating Income | -243.68M |
| Pretax Income | -287.02M |
| Net Income | -252.36M |
| EBITDA | -90.42M |
| EBIT | -243.68M |
| Loss Per Share | -1.82 |
Balance Sheet
The company has 2.72 billion in cash and 982.69 million in debt, with a net cash position of 1.74 billion or 12.50 per share.
| Cash & Cash Equivalents | 2.72B |
| Total Debt | 982.69M |
| Net Cash | 1.74B |
| Net Cash Per Share | 12.50 |
| Equity (Book Value) | 4.71B |
| Book Value Per Share | 10.80 |
| Working Capital | 3.17B |
Cash Flow
In the last 12 months, operating cash flow was -63.10 million and capital expenditures -419.95 million, giving a free cash flow of -483.05 million.
| Operating Cash Flow | -63.10M |
| Capital Expenditures | -419.95M |
| Depreciation & Amortization | 153.26M |
| Net Borrowing | 712.39M |
| Free Cash Flow | -483.05M |
| FCF Per Share | -3.47 |
Margins
Gross margin is 51.80%, with operating and profit margins of -19.21% and -19.89%.
| Gross Margin | 51.80% |
| Operating Margin | -19.21% |
| Pretax Margin | -22.63% |
| Profit Margin | -19.89% |
| EBITDA Margin | -7.13% |
| EBIT Margin | -19.21% |
| FCF Margin | n/a |
Dividends & Yields
TPEX:3176 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.74% |
| Shareholder Yield | 0.74% |
| Earnings Yield | -5.18% |
| FCF Yield | -9.92% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |